These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29983350)

  • 1. Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.
    Nanchahal J; Ball C; Davidson D; Williams L; Sones W; McCann FE; Cabrita M; Swettenham J; Cahoon NJ; Copsey B; Anne Francis E; Taylor PC; Black J; Barber VS; Dutton S; Feldmann M; Lamb SE
    EBioMedicine; 2018 Jul; 33():282-288. PubMed ID: 29983350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial.
    Nanchahal J; Ball C; Rombach I; Williams L; Kenealy N; Dakin H; O'Connor H; Davidson D; Werker P; Dutton SJ; Feldmann M; Lamb SE
    Lancet Rheumatol; 2022 Jun; 4(6):E407-E416. PubMed ID: 35949922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study.
    Nanchahal J; Ball C; Swettenham J; Dutton S; Barber V; Black J; Copsey B; Dritsaki M; Taylor P; Gray A; Feldmann M; Lamb S
    Wellcome Open Res; 2017; 2():37. PubMed ID: 29218326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for early-stage Dupuytren's disease: an evidence-based approach.
    Nanchahal J; Chan JK
    J Hand Surg Eur Vol; 2023 Mar; 48(3):191-198. PubMed ID: 36638105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial.
    Hopewell S; Kenealy N; Knight R; Rangan A; Dutton S; Srikesavan C; Feldmann M; Lamb S; Nanchahal J
    NIHR Open Res; 2022; 2():28. PubMed ID: 37881307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.
    Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S
    BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren's contracture.
    Hindman HB; Marty-Roix R; Tang JB; Jupiter JB; Simmons BP; Spector M
    J Bone Joint Surg Br; 2003 Apr; 85(3):448-55. PubMed ID: 12729127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
    N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
    Kaplan FT
    Drugs Today (Barc); 2011 Sep; 47(9):653-67. PubMed ID: 21971540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupuytren's disease: a localised and accessible human fibrotic disorder.
    Layton TB; Williams L; Nanchahal J
    Trends Mol Med; 2023 Mar; 29(3):218-227. PubMed ID: 36566101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC).
    Williams NH; Jenkins A; Goulden N; Hoare Z; Hughes DA; Wood E; Foster NE; Walsh D; Carnes D; Sparkes V; Hay EM; Isaacs J; Konstantinou K; Morrissey D; Karppinen J; Genevay S; Wilkinson C
    Trials; 2018 Jul; 19(1):408. PubMed ID: 30064491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating inflammatory cytokines alter transcriptional activity within fibrotic tissue of Dupuytren's disease patients.
    Wang ML; Rajpar I; Ruggiero NA; Fertala J; Steplewski A; Beredjiklian PK; Rivlin MR; Chen Y; Feldman GJ; Fertala A; Tomlinson RE
    J Orthop Res; 2022 Mar; 40(3):738-749. PubMed ID: 33913534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.